An Official Website of the United States Government
Company Information:
Name:
KINETA, INC.
Address:
219 Terry Ave N. Suite 300
SEATTLE, WA
SEATTLE, WA
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Agonists of the RIG-I Innate Immune Pathway
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Award Amount:
$585,307.00
Abstract:
DESCRIPTION (provided by applicant): There is a tremendous commercial demand for new antiviral products with novel mechanisms of action and which target a broad spectrum of viruses. Most previous and ongoing pharmaceutical development programs involve scre
ening for inhibitors of essential virus… More
Development of Kv1.3 channel blocker ShK-186 as a therapy for multiple sclerosis
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Shawn P. Iadonato
Award Amount:
$599,443.00
Abstract:
DESCRIPTION (provided by applicant): Multiple sclerosis (MS) affects approximately 400,000 Americans and constitutes a progressive, disabling disease for which current therapies are inadequate. This application describes the nonclinical development of ShK-
186, a novel Kv1.3 potassium channel… More
Agonists of the RIG-I Innate Immune Pathway
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Shawn P. Iadonato – 206-378-0400
Award Amount:
$2,836,489.00
Abstract:
DESCRIPTION (provided by applicant): Through Phase I studies, we have identified five lead small molecule compounds with drug-like properties that activate innate immune response pathways and inhibit the replication of RNA viruses such as hepatitis C virus (HCV), influenza virus (FLU), and West… More